Molly C Carr MD

Diabetes, Lipid Metabolism, Obesity

VP - Clinical head of Insulins and Glucagon Development- Eli Lilly

Summary

Dr. Molly Carr is an endocrinologist based in Philadelphia, PA, with subspecialties in diabetes, lipid metabolism, and obesity. She completed her medical education at Columbia University and furthered her training with a fellowship in endocrinology at the University of Washington. Dr. Carr is currently the Head of Clinical Development for Insulins at Eli Lilly and has held key roles at GlaxoSmithKline. Her research focuses on diabetes and endocrinology, highlighted by multiple publications in prestigious medical journals. She is also an adjunct professor at the Hospital of the University of Pennsylvania. Dr. Carr has received several CMS Meaningful Use Certifications from Epic Systems.

Non-alcoholic fatty liver disease, Diabetes mellitus, Obesity and obesity-related disorders, Lipid metabolism disorders, Endocrinology, Hyperlipidemia, Medical weight loss, Adipose Tissue, Experimental Diabetes Mellitus, Nash, Prospective Studies

University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
University of WashingtonResidency, Internal Medicine, 1994 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017